Provided by Tiger Trade Technology Pte. Ltd.

EVEREST MED

32.120
-0.240-0.74%
Volume:1.73M
Turnover:56.07M
Market Cap:11.37B
PE:-31.30
High:33.280
Open:32.900
Low:32.020
Close:32.360
52wk High:77.550
52wk Low:31.700
Shares:354.00M
HK Float Shares:354.00M
Volume Ratio:0.68
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.026
ROE:-6.35%
ROA:-3.64%
PB:1.86
PE(LYR):-31.30
PS:5.78

Loading ...

Everest Medicines says Milestone consent condition met for asset purchase agreement

Reuters
·
Apr 27

Everest Medicines Issues April 2026 Reminder on Electronic Dissemination of Corporate Communications

Bulletin Express
·
Apr 23

Everest Medicines publishes 2025 environmental, social and governance report

Reuters
·
Apr 23

Everest Medicines publishes 2025 annual report

Reuters
·
Apr 23

Everest MED Shares Climb Over 4% in Morning Session on AACR Data Release

Stock News
·
Apr 21

EVEREST MED Adds 3,250 Shares in March; New 2026 Equity Scheme Opens 35.36 Million-Share Mandate

Bulletin Express
·
Apr 09

BRIEF-Everest Medicines Says Aggregate Consideration Under Share Purchase Agreement Is $250 Million

Reuters
·
Apr 08

EVEREST MED Forges Acquisition Pact with Hisun Biopharm to Broaden Asia-Pacific Commercial Footprint

Stock News
·
Apr 08

Everest Med Plans US$250 Million Acquisition of Hasten’s Singapore Unit to Broaden APAC Chronic-Disease Portfolio

Bulletin Express
·
Apr 08

Everest Medicines signs deal to buy Hasten Biopharmaceuticals SG for US$250 million

Reuters
·
Apr 08

Everest Medicines - Unit to Buy Entire Equity Interest in Hasten Biopharmaceuticals (SG) Pte

THOMSON REUTERS
·
Apr 08

Everest Medicines - Aggregate Consideration Under Share Purchase Agreement Is US$250 Mln

THOMSON REUTERS
·
Apr 08

Everest Medicines' Substantial Shareholder Boosts Stake

MT Newswires Live
·
Mar 30

Major Shareholder Fu Wei Increases Stake in Everest Med by 860,000 Shares

Stock News
·
Mar 30

BRIEF-Everest Medicines Says Honorary Chairman Purchases 860,000 Shares For HK$32.7 Million On March 27

Reuters
·
Mar 30

Everest Medicines - Chairman Purchases 860,000 Shares for HK$32.7 Mln at HK$38.12 per Share on March 27

THOMSON REUTERS
·
Mar 30

Stock Track | EVEREST MED Soars 9.80% Intraday on Strong Annual Results with 142% Revenue Growth and First-Time Profitability

Stock Track
·
Mar 27

EVEREST MED Shares Surge Over 8% in Morning Session on Strong Nefecon Sales and 142% Revenue Growth

Stock News
·
Mar 27

Stock Track | Everest Medicines Plummets 5% Intraday Following Annual Net Loss Report

Stock Track
·
Mar 26

EVEREST MED Reports Fiscal Year Performance with 141.51% Revenue Surge Driven by Strong Nefecon® Sales

Stock News
·
Mar 26